Japan Vaccine files for Japanese approval of intradermal seasonal flu vaccine

Japanese drugmakers Daiichi Sankyo (TYO: 4568) and Terumo Corp (TYO: 4543) say that Japan Vaccine Co, an affiliate of Daiichi Sankyo, has filed an application for the manufacture and sales approval in Japan for an intradermal seasonal influenza vaccine.

The Vaccine is a pre-filled syringe type, intradermal influenza HA vaccine co-developed by four companies (Daiichi Sankyo, Terumo, Japan Vaccine and Kitasato Daiichi Sankyo Vaccine) under a February 23, 2012, agreement between Daiichi Sankyo and Terumo for the co-development of an intradermal vaccine for infectious diseases.

Product uses Terumo injection device